NeurOp, Inc. Company Profile
NeurOp, Inc. is an Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Parkinsonâs disease. Its compounds target the NMDA receptor found on neurons in a manner designed to enhance therapeutic benefit without the negative side effects associated with previous generations of this and other drug classes. A research collaboration and licensing agreement with Bristol-Myers Squibb Company (NYSE: BMY) currently funds and supports development of NeurOpâs compounds for the treatment of depression and neuropathic pain. In 2010, NeurOp collected awards for Start-Up Company of the Year from Emory Universityâs Office of Technology Transfer and Deal of the Year for a Strategic Partnership from Georgia Bio. For more information, visit www.neuropinc.com.
News Articles
NeurOp and Emory Scientists Target Cognitive and Mental Health Disorders
NeurOp, Inc. has formed a research collaboration with Emory University to study modulation of certain brain cell receptors and its possible impact on several serious cognit...
Drugs and Medications
None
PubMed Articles
Dystonic tremor caused by mutation of the glucose transporter gene GLUT1.
Glucose transporter 1 deficiency syndrome (GLUT1-DS) is due to heterozygous mutation of the glucose transporter type 1 gene (GLUT1/SLC2A1). GLUT1-DS is characterized by movement disorders, including p...
Characteristics of tuberous sclerosis in children.
Tuberous sclerosis complex is a genetic multisystem disease characterized by hamartic development of many organs, most notably the brain, heart, kidneys, lungs, and skin. This autosomic dominant disor...
Clinical Trials
None
Companies
NeurOp, Inc. is an Atlanta-based biopharmaceutical company developing new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia (stroke)...
More Information about "NeurOp, Inc." on BioPortfolio
We have published hundreds of NeurOp, Inc. news stories on BioPortfolio along with dozens of NeurOp, Inc. Clinical Trials and PubMed Articles about NeurOp, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeurOp, Inc. Companies in our database. You can also find out about relevant NeurOp, Inc. Drugs and Medications on this site too.
